Group control-after intervention. حسب Nan Tang (642590)

الموضوعات:

Group SFA-before intervention. حسب Nan Tang (642590)

الموضوعات:

Lost cases. حسب Nan Tang (642590)

الموضوعات:

Group control-before intervention. حسب Nan Tang (642590)

الموضوعات:

Patient satisfaction with SFA intervention(%). حسب Nan Tang (642590)

الموضوعات:

Pre-Experiment. حسب Nan Tang (642590)

الموضوعات:

Group SFA-after intervention. حسب Nan Tang (642590)

الموضوعات:

Effects of GJE extract treatment decreased protein expression of MMP-12, α-SMA, IL-13, and TGF-β1 levels. حسب Natnicha Suttawong (22367172)

Tax1bp1-deficiency decreases the frequency of microabscess formation and lymphocyte depletion during <i>L. monocytogenes</i> infection. حسب Jeffrey Chin (22538086)

Flow diagram showing number of subjects included in the study population. حسب Jung-Tae Kim (8997767)

الموضوعات:

This is the raw data used for this study. حسب James M. Friedman (22522150)

الموضوعات:

Pre-operative versus post-operative symptoms. حسب James M. Friedman (22522150)

الموضوعات:

Patient Demographics. حسب James M. Friedman (22522150)

الموضوعات:

Diagnostic Criteria for Human Disharmony Loop. حسب James M. Friedman (22522150)

الموضوعات:

Inhibition of LDHA leads to decreased ATP, reduced AKT phosphorylation, and enhanced chemotherapy sensitivity to LBP in A549 and NCL-H1975 cells. حسب Siyu Yuan (7425719)

الموضوعات:

Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> حسب Razia Rashid Rahil (22772495)

"…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P_i-induced VSMCs. …"

RcbA and RcbB co-operatively decrease motility independent of CaCl₂ concentration. حسب Shobnom Mustaree (21728815)

<i>Porphyromonas gingivalis</i> LPS pretreated by ozone ultrafine bubble water induces decreased TLR2 activation. حسب Mana Endo (22430706)

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

"…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

"…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"